Advertisements

NASDAQ News

Headlines for NASDAQ (NASDAQ01)
Sector News | Topic News
View News From :   To:   Page:    of 3688    
Sat, Jun 23, 2018
4:55 PM Dry Bulk Shipping Industry Analysis - Q1 2018 Edition - SeekingAlpha
4:32 PM Oh Really? Economic Growth To Improve? - SeekingAlpha
3:29 PM Starbucks - Getting More Appealing, Reducing My Entry Target - SeekingAlpha
3:27 PM Dollar Tree: Surviving A Bad Stock Pick - SeekingAlpha
3:06 PM Instructure: Great Value In Hidden Gem - SeekingAlpha
2:45 PM DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against QuinStreet, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm - ACCESSWIRE
2:45 PM DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against QuinStreet, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm - ACCESSWIRE IA
1:30 PM Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care - GlobeNewswire
1:20 PM Can A Sirius XM And Live Nation Marriage Happen? - SeekingAlpha
1:04 PM Weekly Commentary: Performance Chase - SeekingAlpha
1:00 PM ALGT JUNE 25 DEADLINE: Rosen Law Firm Reminds Allegiant Travel Company Investors of Important Deadline in First Filed Class Action- ALGT - Business Wire
1:00 PM QNST JUNE 26 NOTICE: Rosen Law Firm Reminds QuinStreet, Inc. Investors of Important Deadline in First Filed Class Action - QNST - Business Wire
10:25 AM U.S. IPO Weekly Recap: Biotechs Boom In A 13-Deal Torrent - SeekingAlpha
10:17 AM Venture Capital Deals Of The Week: Tencent Bets On Online Education - SeekingAlpha
10:02 AM Will Disney's Epic Buyout Of Fox Mark The End Of The Everything Bubble? - SeekingAlpha
10:01 AM Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewswire
10:00 AM Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions - GlobeNewswire
10:00 AM Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes - GlobeNewswire
10:00 AM MannKind Presents Positive Afrezza\u00AE Clinical Data from STAT and AFFINITY Studies at ADA 78th Scientific Sessions - GlobeNewswire
9:37 AM Recent Stock Purchase June 2018 - SeekingAlpha
9:30 AM Small Caps, Technology And Pharma To Drive A Renewed Market Rally - SeekingAlpha
9:30 AM A Discounted Backdoor Into An 18% Yield - Buyout Should Close Very Soon - SeekingAlpha
9:15 AM Grow Your Income Even When Your Stocks Don't Increase The Dividend - SeekingAlpha
9:00 AM PRTA ALERT: Rosen Law Firm Reminds Prothena Corporation plc Investors of Important Deadline in Case- PRTA - Business Wire
9:00 AM REPH TICKER ALERT: Rosen Law Firm Reminds Recro Pharma, Inc. Investors of Important Deadline in Lawsuit- REPH - Business Wire